Larimar Therapeutics, Inc.

Stocks

LRMR

US5171251003

Market Closed - Nasdaq 16:00:00 2026-10-21 EDT			5-day change	1st Jan Change
2.420 ^USD	-0.82%		+12.04%	-36.48%

09-29	Larimar Therapeutics Names John Harlow COO	MT
09-28	Larimar Therapeutics, Inc. Announces Appointment of John Harlow as President and Chief Operating Officer, Effective September 29, 2026	CI

Transcript : Larimar Therapeutics, Inc. - Special Call

Published on 06/29/2026 at 09:51 am EDT - Modified on 06/29/2026 at 01:35 pm EDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Welcome to the Larimar Therapeutics Investor Event. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be available

This article is reserved for our subscribers.

Subcribe
to read the article

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

Latest news about Larimar Therapeutics, Inc.

09-29	Larimar Therapeutics Names John Harlow COO	MT
09-28	Larimar Therapeutics, Inc. Announces Appointment of John Harlow as President and Chief Operating Officer, Effective September 29, 2026	CI
08-05	Wedbush Adjusts Larimar Therapeutics PT to $11 From $12, Maintains Outperform Rating	MT
08-04	Larimar Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-29	Larimar Therapeutics, Inc.(NasdaqGM:LRMR) added to Russell Small Cap Comp Growth Benchmark	CI
06-29	Larimar Therapeutics, Inc.(NasdaqGM:LRMR) added to Russell 2500 Growth Benchmark	CI
06-29	Larimar Therapeutics, Inc. - Special Call
06-29	Larimar Therapeutics Files First Module of BLA With US FDA for Nomlabofusp	MT
06-29	Larimar Therapeutics, Inc.(NasdaqGM:LRMR) added to Russell Microcap Growth Benchmark Index	CI
06-29	Top Premarket Decliners	MT
06-29	Larimar Therapeutics Submits First Module of Rolling Bla and Reports Positive Open Label Data for Nomlabofusp in Friedreich?S Ataxia	CI
06-29	Larimar Therapeutics, Inc.(NasdaqGM:LRMR) added to Russell 2000 Growth Benchmark	CI
06-29	Larimar Therapeutics, Inc.(NasdaqGM:LRMR) dropped from Russell Small Cap Comp Value Benchmark	CI
06-29	Larimar Therapeutics, Inc.(NasdaqGM:LRMR) added to Russell 3000E Growth Benchmark	CI
06-29	Larimar Therapeutics, Inc.(NasdaqGM:LRMR) dropped from Russell 3000 Value Benchmark	CI